Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Xiamen
Clinical trial register · China

Clinical Trials in Xiamen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Hefei 1 Chongqing 1 Xiamen 1 Zhengzhou 1 Wuhan 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
The First Affiliated Hospital of Xiamen University66 Merck Sharp & Dohme LLC36 Bristol-Myers Squibb11 BeOne Medicines10 AbbVie8 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.6 Xiamen Amoytop Biotech Co., Ltd.5 Ausper Biopharma Co., Ltd.5 RemeGen Co., Ltd.5 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.5 Beijing InnoCare Pharma Tech Co., Ltd.5 Children's Hospital of Fudan University4 Eli Lilly and Company4 Hoffmann-La Roche4 Takeda4 Nanjing Leads Biolabs Co.,Ltd4 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.4 Mirati Therapeutics Inc.4 Genmab4 MediLink Therapeutics (Suzhou) Co., Ltd.3 Biogen3 Hutchmed3 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.3 Xiamen Hospital of Traditional Chinese Medicine3 West China Hospital3 Zai Lab (Shanghai) Co., Ltd.3 Air Force Military Medical University, China3 Xiamen Ophthalmology Center Affiliated to Xiamen University3 Huashan Hospital3 BeiGene3 Shanghai Zhongshan Hospital3 Pfizer3 Celgene3 AstraZeneca3 DualityBio Inc.3 Edwards Lifesciences3 Shanghai Henlius Biotech3 Beijing Tiantan Hospital3 Zhongshan Hospital Xiamen University3 Sun Yat-sen University3 Fudan University3 Allist Pharmaceuticals, Inc.2 Antengene Biologics Limited2 Shanghai Jiao Tong University School of Medicine2 Bayer2 Fujian Provincial Hospital2 Waterstone Pharmaceutical (Wuhan) Co., LTD.2 Xiamen University2 Chinese Academy of Medical Sciences, Fuwai Hospital2 Staidson (Beijing) Biopharmaceuticals Co., Ltd2 Sanofi2 First Affiliated Hospital of Guangxi Medical University2 Hangzhou Sumgen Biotech Co., Ltd.2 Xiamen Cardiovascular Hospital, Xiamen University2 Second Affiliated Hospital, Zhejiang University, School of Medicine2 Hansoh BioMedical R&D Company2 Cascade Pharmaceuticals, Inc2 Beijing Anzhen Hospital2 Ipsen1 Beijing QL Biopharmaceutical Co.,Ltd1 Zhiquan Hu1 Zhuliling1 Bausch & Lomb Incorporated1 Epizyme, Inc.1 Shanghai Hongdian Medical CO., LTD1 ADC Therapeutics S.A.1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 Suzhou HepaThera Biotech Co., Ltd.1 ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.1 Zhuhai Beihai Biotech Co., Ltd1 Exelixis1 Chunshui He1 Hangzhou Converd Co., Ltd.1 Tongji Hospital1 Xiamen Humanity Hospital1 Lepu Medical Technology (Beijing) Co., Ltd.1 Beijing Zhecheng Biotechnology Co., Ltd.1 Pulnovo Medical, Inc.1 Turning Point Therapeutics, Inc.1 BioNTech SE1 Nuvation Bio Inc.1 Fujian Medical University1 Shanghai Huilun Pharmaceutical Co., Ltd.1 Astellas Pharma Global Development, Inc.1 Zhongshan Sansure Hygene Biomedicine Co., Ltd.1 Xintian Pharmaceutical1 Changchun GeneScience Pharmaceutical Co., Ltd.1 Dizal Pharmaceuticals1 Hinova Pharmaceuticals Inc.1 Amgen1 Transcenta Therapeutics (Hangzhou) Co., Ltd.1 Nanjing RegeneCore Biotech Co., Ltd.1 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1 Suzhou Puhe Pharmaceutical Technology Co., LTD1 NucMito Pharmaceuticals Co. Ltd.1 Fujian Medical University Union Hospital1 Zenith Epigenetics1 Novartis Pharmaceuticals1 ArriVent BioPharma, Inc.1 Ocumension Therapeutics (Suzhou) Co., Ltd1 Alpha Biopharma (Jiangsu) Co., Ltd.1 Sichuan Baili Pharmaceutical Co., Ltd.1 Henan Genuine Biotech Co., Ltd.1 Fujian Haixi Pharmaceuticals Co., Ltd.1 First Affiliated Hospital of Fujian Medical University1 Jianyin Zhou1 InSilico Medicine Hong Kong Limited1 Simcere Pharmaceutical Co., Ltd1 Ganzhou Hemay Pharmaceutical Co., Ltd1 First Affiliated Hospital of Zhejiang University1 Genor Biopharma Co., Ltd.1 Yefeng1 OncoC4, Inc.1 Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.1 CStone Pharmaceuticals1 Neuboron Bio-SciTech Co., Ltd.1 Institute of Hematology & Blood Diseases Hospital, China1 Shanghai Allink Biotherapeutics Co., Ltd.1 Tavotek Biotherapeutics1 De-zhi Kang1 Beijing VDJBio Co., LTD.1 Yunxuan Li1 Suzhou Genhouse Bio Co., Ltd.1 Hangzhou GluBio Pharmaceutical Co., Ltd.1 Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 Peking University Cancer Hospital & Institute1 Genentech, Inc.1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1 Zhengrong Huang1 Shanghai Escugen Biotechnology Co., Ltd1 Klus Pharma Inc.1 Shenzhen NewDEL Biotech, Co., Ltd1 Peking University First Hospital1 Sinotau Pharmaceutical Group1 Zhongshan Hospital (Xiamen), Fudan University1 3D Medicines (Sichuan) Co., Ltd.1 Shenzhen Kexing Pharmaceutical Co., Ltd.1 NGGT (Suzhou) Biotechnology Co., Ltd.1 Guangzhou Lupeng Pharmaceutical Company LTD.1 Peijia Medical Technology (Suzhou) Co., Ltd.1 Shanghai Junshi Bioscience Co., Ltd.1 Shanghai Chest Hospital1 Zhejiang University1 Otsuka Pharmaceutical Development & Commercialization, Inc.1 Alebund Pharmaceuticals1 City University of Hong Kong1 Kingdomway (Inner Mongolia) Nutritional Food Co., Ltd.1 First Hospital of China Medical University1 Nanjing Minova Pharmaceutical Co., Ltd.1 Suzhou Hengruihongyuan Medical Technology Co. LTD1 Daiichi Sankyo1 Guangdong Provincial People's Hospital1 Fujian Cancer Hospital1 Akeso1 Cancer Institute and Hospital, Chinese Academy of Medical Sciences1 Tasly Pharmaceutical Group Co., Ltd1 Clear sponsor filter
Target enrolment
to

Trials with a site in Xiamen

1 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Zenith Epigenetics
Phase 2
200
Hefei, Chongqing, Xiamen, Zhengzhou, Wuhan, Changsha, Nanjing, Shenyang
2021-09-08
Rows per page Showing 1–1 of 1
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/xiamen

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1 of those studies with a site in Xiamen that also match the filters currently applied.

How many clinical trials are recruiting in Xiamen?

1 of the 1 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xiamen), 1 studies
PhaseStudiesRecruitingShare
Phase 211100%

Most active sponsors

Lead sponsors with the most studies (Xiamen)
Lead sponsorStudiesRecruiting
Zenith Epigenetics11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.